Status: Not yet recruiting
ASPIRE (Aub-haS2 Plus bIomaRkErs)
ASPIRE is a prospective, multicenter, observational study that will assess the performance of AUB-HAS2 to predict the occurrence of major adverse cardiovascular events 30-days after a non-cardiac surgery and the additional role of high-sensitivity troponin T and NT-ProBNP biomarkers in the accuracy of different event prediction indexes after non-cardiac procedures.
Participants needed: 2,500
Trial details
Age: 40+Biological sex: AllType: ObservationalSponsor: Hospital Samaritano PaulistaUpdated: May 20, 2025Locations: 1
Eligibility criteria
Age ≥ 40 years, in the preoperative period of non-cardiac procedures, with expec...
Refusal to sign the informed consent form.